tiprankstipranks
Trending News
More News >

UBS Increases Stake in Mayne Pharma Group

Story Highlights
UBS Increases Stake in Mayne Pharma Group

Confident Investing Starts Here:

Mayne Pharma Group ( (AU:MYX) ) has issued an update.

UBS Group AG and its related bodies corporate have increased their voting power in Mayne Pharma Group Limited from 7.40% to 8.79% as of April 24, 2025. This change in substantial holding reflects UBS’s strategic interest in Mayne Pharma, potentially impacting the company’s market influence and shareholder dynamics.

More about Mayne Pharma Group

YTD Price Performance: 50.52%

Average Trading Volume: 2,033

Technical Sentiment Signal: Sell

Current Market Cap: $364.5M

Learn more about MYX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App